ImmunityBio, Inc.
ImmunityBio, Inc. (IBRX) Stock Overview
Explore ImmunityBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.5B
P/E Ratio
-6.12
EPS (TTM)
$-0.57
ROE
0.65%
IBRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ImmunityBio, Inc. (IBRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 59.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.38.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.12 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.